What question did this study set out to answer?

This analysis aims to outline the demographics, disease characteristics, and treatment patterns in NMOSD patients treated with inebilizumab.

June 13, 2026Neurology

Inebilizumab for Treatment of NMOSD in a Real-world Cohort: Analysis from the SPHERES Registry (P3-1.012)

View Full Paper

Ask AI

Bookmark

Authors

Analysis describes demographics and treatment patterns in patients with NMOSD receiving inebilizumab.

This analysis aims to outline the demographics, disease characteristics, and treatment patterns in NMOSD patients treated with inebilizumab.
Analysis of data from the SPHERES registry.
Real-world cohort of NMOSD patients.
Assessment of treatment patterns and demographics.
Detailed demographic and disease characteristic data for NMOSD patients using inebilizumab.
Identification of prevalent treatment patterns among the cohort.

Levy et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark